GenSight Biologics Pink Sheet Forecast - Naive Prediction

GSGTF Stock  USD 0.19  0.00  0.00%   
The Naive Prediction forecasted value of GenSight Biologics SA on the next trading day is expected to be 0.19 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. GenSight Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of GenSight Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 18th of January 2026 the relative strength index (rsi) of GenSight Biologics' share price is below 20 . This usually indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of GenSight Biologics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of GenSight Biologics and does not consider all of the tangible or intangible factors available from GenSight Biologics' fundamental data. We analyze noise-free headlines and recent hype associated with GenSight Biologics SA, which may create opportunities for some arbitrage if properly timed.
Using GenSight Biologics hype-based prediction, you can estimate the value of GenSight Biologics SA from the perspective of GenSight Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of GenSight Biologics SA on the next trading day is expected to be 0.19 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.

GenSight Biologics after-hype prediction price

    
  USD 0.19  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Historical Fundamental Analysis of GenSight Biologics to cross-verify your projections.

GenSight Biologics Additional Predictive Modules

Most predictive techniques to examine GenSight price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GenSight using various technical indicators. When you analyze GenSight charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for GenSight Biologics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of GenSight Biologics SA value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

GenSight Biologics Naive Prediction Price Forecast For the 19th of January

Given 90 days horizon, the Naive Prediction forecasted value of GenSight Biologics SA on the next trading day is expected to be 0.19 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict GenSight Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that GenSight Biologics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

GenSight Biologics Pink Sheet Forecast Pattern

Backtest GenSight BiologicsGenSight Biologics Price PredictionBuy or Sell Advice 

GenSight Biologics Forecasted Value

In the context of forecasting GenSight Biologics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. GenSight Biologics' downside and upside margins for the forecasting period are 0.19 and 0.19, respectively. We have considered GenSight Biologics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.19
0.19
Expected Value
0.19
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of GenSight Biologics pink sheet data series using in forecasting. Note that when a statistical model is used to represent GenSight Biologics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria43.506
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
This model is not at all useful as a medium-long range forecasting tool of GenSight Biologics SA. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict GenSight Biologics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for GenSight Biologics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GenSight Biologics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GenSight Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.190.190.19
Details
Intrinsic
Valuation
LowRealHigh
0.160.160.21
Details

Other Forecasting Options for GenSight Biologics

For every potential investor in GenSight, whether a beginner or expert, GenSight Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GenSight Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GenSight. Basic forecasting techniques help filter out the noise by identifying GenSight Biologics' price trends.

GenSight Biologics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GenSight Biologics pink sheet to make a market-neutral strategy. Peer analysis of GenSight Biologics could also be used in its relative valuation, which is a method of valuing GenSight Biologics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

GenSight Biologics Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GenSight Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GenSight Biologics' current price.

GenSight Biologics Market Strength Events

Market strength indicators help investors to evaluate how GenSight Biologics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GenSight Biologics shares will generate the highest return on investment. By undertsting and applying GenSight Biologics pink sheet market strength indicators, traders can identify GenSight Biologics SA entry and exit signals to maximize returns.

Currently Active Assets on Macroaxis

Other Information on Investing in GenSight Pink Sheet

GenSight Biologics financial ratios help investors to determine whether GenSight Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GenSight with respect to the benefits of owning GenSight Biologics security.